Atjaunināt sīkdatņu piekrišanu

Genome-Wide Association Studies: From Polymorphism to Personalized Medicine [Hardback]

Foreword by , Foreword by , Edited by
  • Formāts: Hardback, 432 pages, height x width x depth: 254x180x24 mm, weight: 1050 g, 24 Tables, black and white; 26 Plates, color; 54 Halftones, unspecified; 13 Line drawings, unspecified
  • Izdošanas datums: 14-Jan-2016
  • Izdevniecība: Cambridge University Press
  • ISBN-10: 1107042763
  • ISBN-13: 9781107042766
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 204,27 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 432 pages, height x width x depth: 254x180x24 mm, weight: 1050 g, 24 Tables, black and white; 26 Plates, color; 54 Halftones, unspecified; 13 Line drawings, unspecified
  • Izdošanas datums: 14-Jan-2016
  • Izdevniecība: Cambridge University Press
  • ISBN-10: 1107042763
  • ISBN-13: 9781107042766
Citas grāmatas par šo tēmu:
Over the last twenty years, genome-wide association studies (GWAS) have revealed a great deal about the genetic basis of a wide range of complex diseases and they will undoubtedly continue to have a broad impact as we move to an era of personalised medicine. This authoritative text, written by leaders and innovators from both academia and industry, covers the basic science as well as the clinical, biotechnological and pharmaceutical potential of these methods. With special emphasis given to highlighting pharmacogenomics and population genomics studies using next-generation technology approaches, this is the first book devoted to combining association studies with single nucleotide polymorphisms, copy number variants, haplotypes and expressed quantitative trait loci. A reliable guide for newcomers to the field as well as for experienced scientists, this is a unique resource for anyone interested in how the revolutionary power of genomics can be applied to solve problems in complex disease.

Genome-wide association studies (GWAS) will have increasing importance in the post-genomic era. This timely publication, written by leading experts from academia and industry, provides an essential overview for both established scientists and students, focusing on the use of GWAS in the context of disease biology and personalized medicine.

Recenzijas

'Genome-Wide Association Studies: From Polymorphism to Personalized Medicine, edited by Krishnarao Appasani, summarizes most elegantly the contributions of GWAS as a major discovery tool linking complex disease phenotypes to genetic variants and associated biological pathways and gene networks that were previously unknown. GWAS has transformed the genetic landscape in complex disease and has informed us more about the genetic underpinnings of common diseases and pharmacogenomics traits than any other tool to date. The present book captures this development elegantly and is a pleasure to read.' Hakon Hakonarson, University of Pennsylvania 'From genotype to phenotype: this biological paradigm is now elucidated and extended to the vision of genomic medicine. This highly informative book combines the current knowledge of genome wide association studies with the pathophysiology, epidemiology of human disease, and health condition, especially, implicating in the development of personalized and precision medicine. The combination of technical, scientific, medical, and pharmaco-economic aspects supports the high value of this book for scientists and medical specialists working in the field.' Christine Günther, Chief Executive Officer, apceth GmbH and Co. KG, Munich, Germany 'Through my 30 years' experience in genetics of diabetes, I realize that now is an exciting time in the history of medical genetics thanks to successful genome-wide association studies and challenging whole-genome studies using next-generation sequencing technologies. This excellent book, covering a wide-range of topics and their practical examples in this field, is undoubtedly recommended for readers who are interested in or engaged in genomic medicine.' Takuya Awata, International University of Health and Welfare Hospital, Tochigi, Japan 'Genome-Wide Association Studies: From Polymorphism to Personalized Medicine has an impressive and diverse list of contributors and will become a highly valuable resource for both experts and researchers entering the field.' Jeanette Schmidt, Vice President of Informatics, Affymetrix, Inc., Santa Clara, USA 'This book details how the huge experimental efforts of GWAS can be put into both a biological and medically relevant context, indeed an excellent read for any researcher trying to understand the functional effect of genetic disease association with complex disease.' Tara Caffrey, University of Oxford 'This volume provides a great resource for beginners to learn about the recent advances in GWAS and for domain experts to identity the gaps in the area. The provided software and case studies can guide readers through the procedures and will easily allow a researcher to finish a project on their own. I think this book will be a reliable guide for anyone who wants to learn and understand GWAS. I hope other readers will enjoy the book as much as I did.' Jinliang Yang, The Quarterly Review of Biology

Papildus informācija

Experts from academia and industry highlight the potential of genome-wide association studies from basic science to clinical and biotechnological/pharmaceutical applications.
List of contributors
ix
Forewords xix
Stephen W. Scherer
Peter M. Visscher
Preface xxiii
List of abbreviations
xxvi
Part I Genome-wide association studies
1(66)
1 Introduction to genome-wide association studies and personalized medicine
3(9)
Krishnarao Appasani
Raghu K. Appasani
2 GWAS: a milestone in the road from genotypes to phenotypes
12(14)
Urko M. Marigorta
Juan Antonio Rodriguez
Arcadi Navarro
3 Introduction to statistical methods in genome-wide association studies
26(27)
Can Yang
Cong Li
Dongjun Chung
Mengjie Chen
Joel Gelernter
Hongyu Zhao
4 GWAS replicability across time and space
53(14)
Urko M. Marigorta
Juan Antonio Rodriguez
Arcadi Navarro
Part II Genome-wide studies in disease biology
67(70)
5 Genome-wide association studies of body mass Index
69(10)
Tuomas O. Kilpelainen
6 Identification of myocardial infarction-susceptible genes and their functional analyses
79(10)
Kouichi Ozaki
Toshihiro Tanaka
7 Admixture mapping for disease gene discovery
89(17)
Randall C. Johnson
Cheryl A. Winkler
Meredith Yeager
8 Genome-wide association analysis in schizophrenia
106(17)
Sven Stringer
Dorien H. Nieman
Rene S. Kahn
Eske M. Derks
9 Epigenome-wide association studies in neurodevelopmental disorders
123(14)
Takeo Kubota
Kunio Miyake
Takae Hirasawa
Part III Single nucleotide polymorphisms, copy number variants, haplotypes and eQTLs
137(92)
10 Finding SNPs that affect microRNA regulation in disease-associated genomic regions
139(12)
Laurent F. Thomas
Pal Saetrom
11 From linkage to complex associations: the role of GABRA2 as a risk factor for alcohol use
151(17)
Sandra M. Villafuerte
Elisa M. Trucco
Margit Burmeister
12 Copy number variation in monozygous twins
168(25)
Erwin Brosens
K.G. Snoek
D. Veenma
H. Eussen
D. Tibboel
A. de Klein
13 Haplotypes of CpG-related SNPs and associations with DNA methylation patterns
193(15)
Yiyi Ma
Caren E. Smith
Yu-Chi Lee
Laurence D. Parnell
Chao-Qiang Lai
Jose M. Ordovas
14 eQTL mapping
208(21)
Mengjie Chen
Can Yang
Cong Li
Hongyu Zhao
Part IV Next-generation sequencing technology and pharmaco-genomics
229(84)
15 Next-generation sequencing for rare diseases
231(12)
Elena Bosch
Ferran Casals
16 Next-generation sequencing for complex disorders
243(12)
Ferran Casals
Elena Bosch
17 Chromosomal breakpoints in breast cancer co-localize with differentially methylated regions
255(14)
Man-Hung Eric Tang
Vinay Varadan
Sitharthan Kamalakaran
Michael Q. Zhang
James Hicks
Nevenka Dimitrova
18 Signaling network analysis of genomic alterations predicts breast cancer drug targets
269(12)
Naif Zaman
Edwin Wang
19 Pharmacogenetic studies in pediatric acute myeloid leukemia
281(16)
Neha S. Bhise
Lata Chauhan
Jatinder Kaur Lamba
20 Pharmaco-genomics of antiretroviral drugs
297(16)
Chonlaphat Sukasem
Apichaya Puangpetch
Sadeep Medhasi
Part V Population genetics and personalized medicine
313(70)
21 Population stratification and its implications: lessons from genome-wide studies
315(26)
Sheikh Nizamuddin
Rakesh Tamang
Kumarasamy Thangaraj
22 How to solve genetic disease on a population scale
341(25)
Barry Merriman
23 Economics of personalized medicine
366(17)
Katherine Payne
Martin Eden
Index 383
Krishnarao Appasani is the Founder and Chief Executive Officer of GeneExpression Systems, a global conference-producing organization focusing on biomedical and physical sciences. He is an award-winning scientist and the editor of Epigenomics: From Chromatin Biology to Therapeutics (2012), MicroRNAs: From Basic Science to Disease Biology (2007) and RNA Interference: From Basic Science to Drug Development (2005), all published by Cambridge University Press.